Advertisement

Topics

Sage to pursue accelerated development plan for antidepressant therapy

06:27 EDT 13 Jun 2018 | SmartBrief

An accelerated development plan is set to be implemented by Sage Therapeutics for antidepressant candidate SAGE-217 after a b -More

Original Article: Sage to pursue accelerated development plan for antidepressant therapy

NEXT ARTICLE

More From BioPortfolio on "Sage to pursue accelerated development plan for antidepressant therapy"

Advertisement
Quick Search
Advertisement
Advertisement